tiprankstipranks
Trending News
More News >
Lyra Therapeutics (LYRA)
NASDAQ:LYRA
US Market
Advertisement

Lyra Therapeutics (LYRA) Technical Analysis

Compare
360 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Lyra Therapeutics’s (LYRA) Moving Averages Convergence Divergence (MACD) indicator is -0.69, suggesting Lyra Therapeutics is a Buy.
Lyra Therapeutics’s (LYRA) 20-Day exponential moving average is 10.11, while Lyra Therapeutics’s (LYRA) share price is $8.64, making it a Sell.
Lyra Therapeutics’s (LYRA) 50-Day exponential moving average is 9.93, while Lyra Therapeutics’s (LYRA) share price is $8.64, making it a Sell.

Lyra Therapeutics (LYRA) Pivot Points

Jul 15, 2025, 12:30 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.04
8.29
8.47
8.72
8.90
9.15
9.33
Fibonacci
8.29
8.46
8.56
8.72
8.89
8.99
9.15
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lyra Therapeutics (LYRA) Moving Averages

Jul 15, 2025, 12:30 PM
Period
Simple
Exponential
MA5
8.99Sell
8.92Sell
MA10
9.02Sell
9.36Sell
MA20
10.17Sell
10.11Sell
MA50
9.76Sell
9.93Sell
MA100
8.55Buy
9.52Sell
MA200
9.63Sell
10.57Sell
Lyra Therapeutics’s (LYRA) 10-Day exponential moving average is 9.36, while Lyra Therapeutics’s (LYRA) share price is $8.64, making it a Sell.
Lyra Therapeutics’s (LYRA) 100-Day exponential moving average is 9.52, while Lyra Therapeutics’s (LYRA) share price is $8.64, making it a Sell.
Lyra Therapeutics’s (LYRA) stock price is $8.64 and Lyra Therapeutics’s (LYRA) 50-day simple moving average is 9.76, creating a Sell signal.
Lyra Therapeutics’s (LYRA) stock price is $8.64 and Lyra Therapeutics’s (LYRA) 100-day simple moving average is 8.55, creating a Buy signal.
Lyra Therapeutics’s (LYRA) stock price is $8.64 and Lyra Therapeutics’s (LYRA) 200-day simple moving average is 9.63, creating a Sell signal.

Lyra Therapeutics (LYRA) Technical Indicators

Jul 15, 2025, 12:30 PM
Name
Value
Implied Action
RSI (14)
43.47
Neutral
STOCH (9,6)
33.90
Neutral
STOCHRSI (14)
6.94
Buy
MACD (12,26)
-0.69
Buy
ADX (14)
21.71
Neutral
Williams %R
-94.49
Buy
CCI (14)
-77.88
Neutral
ATR (14)
1.64
-
Ultimate Oscillator
46.45
Neutral
ROC
-24.19
Sell
Lyra Therapeutics’s (LYRA) Relative Strength Index (RSI) is 43.47, creating a Neutral signal.
Lyra Therapeutics’s (LYRA) Trend Strength Indicator (ADX) is 21.71, creating a Neutral signal.
Lyra Therapeutics’s (LYRA) Commodity Channel Index (CCI) is -77.88, creating a Neutral signal.
Lyra Therapeutics’s (LYRA) Price Rate of Change (ROC) is -24.19, creating a Sell signal.

FAQ

Is LYRA a Buy, Hold, or Sell?
Based on LYRA’s technical indicators, LYRA is a Sell.
    What is LYRA’s RSI (14)?
    LYRA’s RSI (14) is 43.47, which suggests LYRA is a Neutral.
      What is LYRA’s MACD?
      LYRA’s MACD is -0.69, which suggests LYRA is a Buy.
        What is LYRA’s 5-day moving average?
        LYRA’s 5-day moving average is 8.99, which suggests LYRA is a Sell.
          What is LYRA’s 20-day moving average?
          LYRA 20-day moving average is 10.17, which suggests LYRA is a Sell.
            What is LYRA’s 50-day moving average?
            LYRA’s 50-day moving average is 9.76, which suggests LYRA is a Sell.
              What is LYRA’s 200-day moving average?
              LYRA’s 200-day moving average is 9.63, which suggests LYRA is a Sell.
                What is LYRA’s Williams % R (14)?
                LYRA’s Williams % R (14) is -94.49, which suggests LYRA is a Buy.
                  What is LYRA’s CCI (14)?
                  LYRA’s CCI (14) is -77.88, which suggests LYRA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis